Supplementary Figure 3 from Harnessing the Fcμ Receptor for Potent and Selective Cytotoxic Therapy of Chronic Lymphocytic Leukemia
crossref（2023）
摘要
Supplementary Figure 3 shows that unconjugated Fcµ-Sec has no anti-tumor activity.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要